Scientif Platform Presentation II

Tuesday, October 23, 2012: 10:15 AM-12:15 PM
Westin Diplomat Resort
10:15 AM
150
An evaluation of the drug-drug interaction between Proton-Pump Inhibitors and EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Patients
Alexandre Chan, Pharm.D., MPH1, Bingrong Chen, BScPharm(Hon)1, Raymond Ng, MBChB, FRACP, MPH2, Wei-Peng Yong, MBChB, MRCP3 and Yu Ko, Ph.D.1
1National University of Singapore, Singapore, Singapore
2National Cancer Centre Singapore, Singapore, Singapore
3National University Cancer Institute, Singapore, Singapore
10:35 AM
94
Does a pharmacist care management program improve hypertension outcomes in Veterans?
Alan J. Zillich, PharmD1, Heather A. Jaynes, RN, MSN1, Susan D. Bex, PharmD, BCPS2, Amy S. Boldt, PharmD2, Darin C. Ramsey, PharmD2, Cassandra M. Walston, PharmD2 and Dawn M. Bravata, MD2
1Purdue University College of Pharmacy, Indianapolis, IN
2Richard L. Roudebush VA Medical Center, Indianapolis, IN
10:55 AM
188
The effect of NAD(P)H dehydrogenase, quinone 1 genotype on warfarin dose requirements in Hispanic and African Americans
Adam P. Bress, Pharm.D.1, Shitalben R. Patel, M.S.2, Minoli Perera, Pharm.D., Ph.D.3, Richard T. Campbell, Ph.D.1, Rick Kittles, Ph.D.1 and Larisa H. Cavallari, Pharm.D.1
1University of Illinois at Chicago, Chicago, IL
2University of Illinois at Chicago College of Pharmacy, Chicago, IL
3University of Chicago, Chicago, IL
11:15 AM
100
Assessment of warfarin requirements in post-bariatric surgery patients
Adriane N. Irwin, MS, PharmD, Kathleen H. McCool, PharmD, Thomas Delate, PhD, MS and Daniel M. Witt, PharmD
Kaiser Permanente Colorado, Aurora, CO
11:35 AM
92
Psychotropic use monitoring for nursing home residents with dementia
Kai Zhen Yap, BSc, (Pharm)(Hons)1, Joyce Y. Lee, PharmD1, Ee Heok Kua, MBBS, MD, FRCPsych, PBM2 and Sui Yung Chan, BSc, (Pharm)(Hons), MBA, PhD1
1National University of Singapore, Singapore, Singapore
2National University Health System, Singapore, Singapore
12:15 PM
41
CHA2DS2-VASc score is associated with post-cardiothoracic surgery atrial fibrillation
William L. Baker Jr., Pharm.D.1, Craig I. Coleman, PharmD2, C. Michael White, PharmD, FCCP, FCP2 and Jeffrey Kluger, MD3
1University of Connecticut School of Pharmacy
2University of Connecticut, Hartford, CT
3Hartford Hospital, Hartford, CT
See more of: Original Research